These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 39044584

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A Simple Mouse Model for the Study of Human Immunodeficiency Virus.
    Kim KC, Choi BS, Kim KC, Park KH, Lee HJ, Cho YK, Kim SI, Kim SS, Oh YK, Kim YB.
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):194-202. PubMed ID: 26564392
    [Abstract] [Full Text] [Related]

  • 3. Monitoring HIV DNA and cellular activation markers in HIV-infected humanized mice under cART.
    Rochat MA, Schlaepfer E, Kuster SP, Li D, Audige A, Ivic S, Fahrny A, Speck RF.
    Virol J; 2018 Dec 17; 15(1):191. PubMed ID: 30558630
    [Abstract] [Full Text] [Related]

  • 4. Establishment of a Novel Humanized Mouse Model To Investigate In Vivo Activation and Depletion of Patient-Derived HIV Latent Reservoirs.
    Flerin NC, Bardhi A, Zheng JH, Korom M, Folkvord J, Kovacs C, Benko E, Truong R, Mota T, Connick E, Jones RB, Lynch RM, Goldstein H.
    J Virol; 2019 Mar 15; 93(6):. PubMed ID: 30626677
    [Abstract] [Full Text] [Related]

  • 5. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ, Connors M, Flanigan ME, Geiger SP, Ford H, Baseler M, Adelsberger J, Davey RT, Lane HC.
    J Immunol; 1995 Jun 15; 154(12):6612-23. PubMed ID: 7759895
    [Abstract] [Full Text] [Related]

  • 6. HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients.
    Re MC, Vitone F, Biagetti C, Schiavone P, Alessandrini F, Bon I, de Crignis E, Gibellini D.
    Clin Microbiol Infect; 2010 Jun 15; 16(6):640-6. PubMed ID: 19732081
    [Abstract] [Full Text] [Related]

  • 7. Novel Humanized Peripheral Blood Mononuclear Cell Mouse Model with Delayed Onset of Graft-versus-Host Disease for Preclinical HIV Research.
    Holguin L, Echavarria L, Burnett JC.
    J Virol; 2022 Feb 09; 96(3):e0139421. PubMed ID: 34818071
    [Abstract] [Full Text] [Related]

  • 8. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique.
    Gibellini D, Vitone F, Schiavone P, Ponti C, La Placa M, Re MC.
    J Clin Virol; 2004 Apr 09; 29(4):282-9. PubMed ID: 15018857
    [Abstract] [Full Text] [Related]

  • 9. High-Throughput Humanized Mouse Models for Evaluation of HIV-1 Therapeutics and Pathogenesis.
    Thomas T, Seay K, Zheng JH, Zhang C, Ochsenbauer C, Kappes JC, Goldstein H.
    Methods Mol Biol; 2016 Apr 09; 1354():221-35. PubMed ID: 26714715
    [Abstract] [Full Text] [Related]

  • 10. Peripheral blood mononuclear cell human immunodeficiency virus type 1 proviral DNA quantification by polymerase chain reaction: relationship to immunodeficiency and drug effect.
    Montoya JG, Wood R, Katzenstein D, Holodny M, Merigan TC.
    J Clin Microbiol; 1993 Oct 09; 31(10):2692-6. PubMed ID: 7902845
    [Abstract] [Full Text] [Related]

  • 11. Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1.
    Kollmann TR, Pettoello-Mantovani M, Zhuang X, Kim A, Hachamovitch M, Smarnworawong P, Rubinstein A, Goldstein H.
    J Exp Med; 1994 Feb 01; 179(2):513-22. PubMed ID: 8294863
    [Abstract] [Full Text] [Related]

  • 12. Infection of baboons with a simian immunodeficiency virus/HIV-1 chimeric virus constructed with an HIV-1 Thai subtype E envelope.
    Klinger JM, Himathongkham S, Legg H, Luciw PA, Barnett SW.
    AIDS; 1998 May 28; 12(8):849-57. PubMed ID: 9631137
    [Abstract] [Full Text] [Related]

  • 13. Application of a commercial kit for detection of PCR products to quantification of human immunodeficiency virus type 1 RNA and proviral DNA.
    Lin HJ, Haywood M, Hollinger FB.
    J Clin Microbiol; 1996 Feb 28; 34(2):329-33. PubMed ID: 8789009
    [Abstract] [Full Text] [Related]

  • 14. Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR.
    Damond F, Descamps D, Farfara I, Telles JN, Puyeo S, Campa P, Leprêtre A, Matheron S, Brun-Vezinet F, Simon F.
    J Clin Microbiol; 2001 Dec 28; 39(12):4264-8. PubMed ID: 11724830
    [Abstract] [Full Text] [Related]

  • 15. Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents.
    Persaud D, Patel K, Karalius B, Rainwater-Lovett K, Ziemniak C, Ellis A, Chen YH, Richman D, Siberry GK, Van Dyke RB, Burchett S, Seage GR, Luzuriaga K, Pediatric HIV/AIDS Cohort Study.
    JAMA Pediatr; 2014 Dec 28; 168(12):1138-46. PubMed ID: 25286283
    [Abstract] [Full Text] [Related]

  • 16. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay.
    Désiré N, Dehée A, Schneider V, Jacomet C, Goujon C, Girard PM, Rozenbaum W, Nicolas JC.
    J Clin Microbiol; 2001 Apr 28; 39(4):1303-10. PubMed ID: 11283046
    [Abstract] [Full Text] [Related]

  • 17. Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain.
    Koyanagi Y, Tanaka Y, Kira J, Ito M, Hioki K, Misawa N, Kawano Y, Yamasaki K, Tanaka R, Suzuki Y, Ueyama Y, Terada E, Tanaka T, Miyasaka M, Kobayashi T, Kumazawa Y, Yamamoto N.
    J Virol; 1997 Mar 28; 71(3):2417-24. PubMed ID: 9032379
    [Abstract] [Full Text] [Related]

  • 18. T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells.
    Rizza P, Santini SM, Logozzi MA, Lapenta C, Sestili P, Gherardi G, Lande R, Spada M, Parlato S, Belardelli F, Fais S.
    J Virol; 1996 Nov 28; 70(11):7958-64. PubMed ID: 8892919
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of in vivo HIV infection in humanized mice by gene therapy of human hematopoietic stem cells with a lentiviral vector encoding a broadly neutralizing anti-HIV antibody.
    Joseph A, Zheng JH, Chen K, Dutta M, Chen C, Stiegler G, Kunert R, Follenzi A, Goldstein H.
    J Virol; 2010 Jul 28; 84(13):6645-53. PubMed ID: 20410262
    [Abstract] [Full Text] [Related]

  • 20. The Establishment of an In Vivo HIV-1 Infection Model in Humanized B-NSG Mice.
    Fan TJ, Sun L, Yang XG, Jin X, Sun WW, Wang JH.
    Virol Sin; 2020 Aug 28; 35(4):417-425. PubMed ID: 31863357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.